PRMT5 and gastric cancer: (24) found that the expression levels of c-MYC and PRMT5 were up-regulated in human primary gastric cancer tissues, and the PRMT5-dependent transcriptional repression of c-MYC target genes was necessary for gastric cancer progression, which provided a potential new strategy for the targeted treatment of gastric cancer.